Pfizer says it's eyeing a $110 to $130 list price for COVID-19 vaccine in U.S.
October 21, 2022 at 16:29 PM EDT
Pfizer Inc. on Thursday revealed the possible U.S. list price it is eyeing for its adult COVID-19 vaccine doses once the shot hits the commercial market.
